MDSCs are a heterogenous group of CD33 positive myeloid-derived cells, which are typically CD14 positive monocytic MDSCs or CD14 negative granulocytic MDSCs,59 the latter being more prevalent in MM patients.60 These cells have numerous immunosuppressive activities, facilitating tumor survival. Here, CD14 is linked to Miyoshi myopathy.